1. Pink Sheet
  2. >>Legislation

FDA Would Get Less Funding, Different Inspection Priorities Under Senate Legislation Than House

 
• By Derrick Gingery

CDER would lose the most money in the Senate appropriations bill compared to the House version, while CBER would see an increase.

US Senate exterior
The Senate Appropriations Committee reduced the increase the House gave to CDER, but boosted the additional funds for CBER. • Source: Alamy

Senators offered the US Food and Drug Administration less funding for fiscal year 2022, along with an alternative direction on facility inspections, compared to their colleagues in the House of Representatives.

The

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Pink Sheet